IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Siren, L.L.C.

Q4 2025 Holdings

Filed 2026-02-13 | 115 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$71.7M3,007,0772.1%
Tango Therapeutics Inc(TNGX)COM87583X109$72.3M8,165,3742.2%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$75.0M1,078,6982.2%
Disc Medicine Inc(IRON)COM254604101$78.5M988,4012.3%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$82.5M3,300,7002.5%
Bicara Therapeutics Inc(BCAX)COM055477103$87.8M5,216,9692.6%
Arrowhead Pharmaceuticals Inc(ARWR)COM04280A100$99.6M1,500,4763.0%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$100.7M4,027,5173.0%
Revolution Medicines Inc(RVMD)COM76155X100$106.3M1,335,0753.2%
Edgewise Therapeutics Inc(EWTX)COM28036F105$112.4M4,529,9903.4%
BeOne Medicines AG(ONC)SPONSORED ADS07725L102$151.9M500,0004.5%
Kymera Therapeutics Inc(KYMR)COM501575104$255.7M3,286,8307.6%
Scholar Rock Holding Corp(SRRK)COM80706P103$476.8M10,825,01314.2%
PreviousPage 3 of 3